Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-02-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.5bn
reported value
+53.5% vs Q3 2023
36positions
68.3%in top 10
8 new
13 added
7 reduced
9 sold out
vs Q3 2023
Holdings, Q4 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| RAYZEBIO INC COM | $250.6m17.19% | Added +13.6k |
| APOGEE THERAPEUTICS INC COM | $237.3m16.28% | Unchanged |
| PHARVARIS N V PHVS | $95.2m6.53% | Added +1.8m |
| VIRIDIAN THERAPEUTICS INC VRDN | $84.6m5.80% | Added +800.0k |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $69.4m4.76% | Added +424.0k |
| MERUS N V MRUS | $59.1m4.05% | Added +422.0k |
| CABALETTA BIO INC CABA | $58.2m3.99% | Added +590.7k |
| SPYRE THERAPEUTICS INC SYRE | $51.1m3.50% | New |
| KALVISTA PHARMACEUTICALS INC KALV | $50.1m3.44% | Added +1.2m |
| ENLIVEN THERAPEUTICS INC ELVN | $40.9m2.80% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $34.7m2.38% | New |
| HILLEVAX INC COM | $33.3m2.28% | Added +37.7k |
| AMBRX BIOPHARMA INC COM | $29.5m2.02% | New |
| TERNS PHARMACEUTICALS INC COM | $29.2m2.00% | Added +1.4m |
| DYNE THERAPEUTICS INC DYN | $28.9m1.98% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $27.5m1.89% | Unchanged |
| CELCUITY INC CELC | $27.5m1.88% | Reduced -219.8k |
| MERSANA THERAPEUTICS INC COM | $26.3m1.80% | Unchanged |
| ARVINAS INC ARVN | $25.8m1.77% | New |
| ASTRIA THERAPEUTICS INC CATB | $24.8m1.70% | New |
| RHYTHM PHARMACEUTICALS INC RYTM | $22.8m1.56% | Reduced -594.0k |
| ORIC PHARMACEUTICALS INC ORIC | $22.3m1.53% | Added +285.5k |
| APPLIED THERAPEUTICS INC APLT | $20.9m1.44% | Added +592.0k |
| TAYSHA GENE THERAPIES INC TSHA | $18.4m1.26% | Reduced -4.0m |
| SAVARA INC SVRA | $16.4m1.13% | Reduced -3.7m |
| LYRA THERAPEUTICS INC LYRA | $13.5m0.93% | Added +1.7m |
| ABIVAX SA ABVX | $10.7m0.73% | New |
| DIANTHUS THERAPEUTICS INC DNTH | $9.6m0.66% | Unchanged |
| PRAXIS PRECISION MEDICINES I PRAX | $7.9m0.54% | New |
| GH RESEARCH PLC GHRS | $7.6m0.52% | Reduced -1.4m |
| ACELYRIN INC COM | $7.0m0.48% | Added +72.8k |
| EYEPOINT PHARMACEUTICALS INC EYPT | $5.8m0.40% | New |
| TREVI THERAPEUTICS INC TRVI | $4.6m0.31% | Unchanged |
| ADVERUM BIOTECHNOLOGIES INC COM | $3.9m0.27% | Reduced -1.4m |
| MILESTONE PHARMACEUTICALS IN MIST | $1.5m0.11% | Reduced -1.3m |
| OLEMA PHARMACEUTICALS INC OLMA | $1.1m0.07% | Unchanged |
Sold out since Q3 2023
| Security | Value then |
|---|---|
| AMBRX BIOPHARMA INC | $23.8m2.1m shares |
| TRAVERE THERAPEUTICS INC TVTX | $23.5m2.6m shares |
| PRAXIS PRECISION MEDICINES I | $9.1m5.3m shares |
| ACLARIS THERAPEUTICS INC ACRS | $7.1m1.0m shares |
| PLIANT THERAPEUTICS INC PLRX | $5.0m288.9k shares |
| SAGIMET BIOSCIENCES INC SGMT | $4.5m515.0k shares |
| AEGLEA BIOTHERAPEUTICS INC AGLE | $3.6m295.0k shares |
| RALLYBIO CORP | $905.0k268.5k shares |
| AFFIMED N V | $682.7k1.4m shares |